Pharmaceutical industry
Life Medical Sciences, Inc., a New Jersey-based company, has announced a plan to convert $638,313 of principal and accrued interest into 283,695 shares of common stock. The conversion is a result of a Board of Directors resolution, permitting the debt-to-equity swap for Dr. Herbert Moskowitz, Mr. Irwin M.
Pharmaceutical industry
Boots, the British pharmacy chain, has reported a 66 per cent increase in interim pre-tax profits, driven by strong demand for branded drugs and a £47.8m gain from the sale of the Farley baby foods business. The group's underlying sales and profits performance was described as "
Pharmaceutical industry
The proposed Smoke Free Air Act, introduced by New York City Council Speaker Peter E. Vallone in March, aims to eliminate smoking in most public areas, but lobbying efforts by the tobacco industry have weakened the bill. Philip Morris Cos. has threatened to relocate its headquarters, which employs 2,000
Pharmaceutical industry
IBM's latest innovation in speech recognition, VoiceType Dictation, has the potential to transform the way people interact with their computers. This cutting-edge technology allows users to bypass the keyboard and mouse by talking directly to the PC, providing a game-changing solution for individuals with disabilities, those suffering from
Pharmaceutical industry
GeneMedicine Inc., a pharmaceutical company specializing in gene therapy, has announced a collaborative agreement with Vanderbilt University Medical Center to develop pulmonary gene therapy methods. The partnership aims to explore the use of non-viral gene medicines to express the alpha-1 antitrypsin gene, which inhibits inflammatory damage to the lungs and
Drugs
Genentech, Inc. has denied any wrongdoing in regards to the Food and Drug Administration (FDA) probe of its marketing practices, calling reports "old news." The company has been cooperating with the FDA for months and has discussed the investigation publicly. Genentech's president and CEO, G. Kirk
Drugs
Data presented at the American Academy of Ophthalmology meeting in San Francisco showed that BetaKine, a therapeutic agent developed by Celtrix Pharmaceuticals, demonstrated significant efficacy in treating patients with macular holes, a retinal condition that causes loss of central vision. The study, conducted at the Bascom Palmer Eye Institute and
Drugs
Ixsys, a leader in molecular design, has announced that it has received an exclusive license from Hoechst Japan Ltd. for rights to a family of monoclonal antibodies, including all forms of MRK-16 and MRK-17, which reverse the resistance of tumor cells to chemotherapy. This license allows Ixsys to develop a
